Armodafinil vs Piracetam

Side-by-side comparison of mechanisms, dosing, interactions, and stacking potential.

ArmodafinilPiracetam
CategoryNootropicsNootropics
Standard Dose75-150 mg once daily (for educational context only — prescription medication in most jurisdictions)1200-4800 mg/day divided into 2-3 doses
TimingEarly morning. 150 mg armodafinil provides comparable late-day wakefulness to 200 mg modafinil. Food delays Tmax by ~2-4 hours but does not affect total absorption. Half-life approximately 15-16.5 hours.With or without food; split doses morning and afternoon to maintain plasma levels
Cycle DurationSame as modafinil; not typically cycled in clinical use.Cycles of 8-12 weeks on, 4 weeks off; or ongoing with periodic reassessment
Evidence Levelstrong_humanmoderate_human
A

Armodafinil

Nootropics

Mechanism

The isolated R-enantiomer of racemic modafinil, sharing the same primary mechanism — selective inhibition of the dopamine transporter (DAT) — but with distinct pharmacokinetics. The R-enantiomer has a terminal half-life of ~15 hours vs. ~4-5 hours for the S-enantiomer, resulting in 33-40% higher plasma AUC compared to equimolar racemic modafinil. This translates to more sustained wakefulness-promoting activity throughout the day. Same downstream activation of orexinergic, histaminergic, and noradrenergic pathways as modafinil.

Standard Dosing

75-150 mg once daily (for educational context only — prescription medication in most jurisdictions)

Timing

Early morning. 150 mg armodafinil provides comparable late-day wakefulness to 200 mg modafinil. Food delays Tmax by ~2-4 hours but does not affect total absorption. Half-life approximately 15-16.5 hours.

Cycle Duration

Same as modafinil; not typically cycled in clinical use.

Side Effects

  • Headache
  • Nausea
  • Dizziness
  • Insomnia (more pronounced than modafinil due to longer half-life)
  • Anxiety
  • Dry mouth
  • Diarrhea
  • Stevens-Johnson syndrome (very rare)

Contraindications

  • Same as modafinil: mitral valve prolapse, left ventricular hypertrophy, severe hepatic impairment, severe anxiety/psychotic disorders, hypersensitivity, pregnancy

Best Stacking Partners

L-TheanineAlpha-GPCMagnesium
B

Piracetam

Nootropics

Mechanism

Positive allosteric modulator of AMPA receptors, binding at a unique site along the dimer interface to reduce desensitization and deactivation. Inhibits N-type calcium channels at clinically relevant CNS concentrations. Enhances membrane fluidity of neuronal phospholipids and modulates neurotransmission across cholinergic and glutamatergic systems.

Standard Dosing

1200-4800 mg/day divided into 2-3 doses

Timing

With or without food; split doses morning and afternoon to maintain plasma levels

Cycle Duration

Cycles of 8-12 weeks on, 4 weeks off; or ongoing with periodic reassessment

Side Effects

  • Headache (often from inadequate choline)
  • Insomnia
  • GI discomfort
  • Irritability at high doses

Contraindications

  • Severe renal impairment (renally excreted)
  • Huntington's disease
  • Cerebral hemorrhage

Best Stacking Partners

Alpha-GPCCDP-CholineAniracetamLion's Mane

Not sure which is right for you?

Take our free assessment to get personalized recommendations based on your health goals, current stack, and biomarkers.

Get Your Free Protocol →or take the assessment →